FDA approves selegiline transdermal for the treatment of major depressive disorder in adults

被引：0
|
作者：
Naccari, C
机构：
来源：
CNS SPECTRUMS | 2006年 / 11卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [41] Major Depressive Disorder in Older Adults: Benefits and Hazards of Prolonged Treatment
    Diniz, Breno S.
    Reynolds, Charles F., III
    DRUGS & AGING, 2014, 31 (09) : 661 - 669
  • [42] Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder
    Cohen, Alex
    PSYCHIATRIC SERVICES, 2023, 74 (02) : 214 - 215
  • [43] Major Depressive Disorder in Older Adults: Benefits and Hazards of Prolonged Treatment
    Breno S. Diniz
    Charles F. Reynolds
    Drugs & Aging, 2014, 31 : 661 - 669
  • [44] Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder
    Mills, Jeffrey A.
    Suresh, Vikram
    Chang, Lenisa
    Mayes, Taryn
    Croarkin, Paul E.
    Trivedi, Madhukar H.
    Strawn, Jeffrey R.
    PSYCHIATRIC SERVICES, 2022, 73 (09) : 965 - 969
  • [45] Safety and tolerability of the selegiline transdermal system 20 mg for treatment of major depression
    Robinson, DS
    Campbell, BJ
    Amsterdam, JD
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S234 - S234
  • [46] Selegiline transdermal system in major depressive disorder - Profile report (Reprinted from Drugs, vol 67, pg 257-267, 2007)
    Frampton, James E.
    Plosker, Greg L.
    CNS DRUGS, 2007, 21 (06) : 521 - 524
  • [47] FDA approves DMD treatment
    不详
    C&EN GLOBAL ENTERPRISE, 2024, 102 (10): : 15 - 15
  • [48] FDA approves TB treatment
    Brainard, Jeffrey
    SCIENCE, 2019, 365 (6455) : 726 - 727
  • [49] FDA approves carbamazepine extended-release for the treatment of bipolar disorder
    不详
    CNS SPECTRUMS, 2005, 10 (02) : 82 - 82
  • [50] FDA approves treatment for adults and children with all genotypes of hepatitis C
    不详
    NURSE PRACTITIONER, 2020, 45 (01): : 56 - 56
12345